Supervisory shortcomings, rather than problems with a vaccine itself, led to the death of a baby girl in India last fall during a Wyeth clinical trial, according to an official investigation by India's top drug regulator.
The findings by the Drugs Controller General of India are likely to add to concerns about how well Western pharmaceutical companies oversee human testing of potential new medicines in developing countries.
More at WSJ
Monday, March 23, 2009
Slumdog Clinical Trials contd. - the case of Wyeth's Prevnar
Subscribe to:
Post Comments (Atom)
2 comments:
Can you please elaborate as to how supervisory shortcomings are to be blamed than the vaccine being tested?
Post a Comment